These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7507361)

  • 1. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII.
    Schousboe I; Rasmussen MS; Lintner R
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):503-9. PubMed ID: 7841305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.
    Schousboe I; Rasmussen MS
    Thromb Haemost; 1995 May; 73(5):798-804. PubMed ID: 7482406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The autoactivation of factor XII in the presence of long-chain saturated fatty acids--a comparison with the potency of sulphatides and dextran sulphate.
    Mitropoulos KA; Esnouf MP
    Thromb Haemost; 1991 Oct; 66(4):446-52. PubMed ID: 1796394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XII does not initiate prekallikrein activation on endothelial cells.
    Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
    Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Jul; 102(1):31-45. PubMed ID: 6343536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor).
    Tans G; Rosing J; Griffin JH
    J Biol Chem; 1983 Jul; 258(13):8215-22. PubMed ID: 6553053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of surface-dependent autocatalytic activation of blood coagulation factor XII by divalent metal ions.
    Shore JD; Day DE; Bock PE; Olson ST
    Biochemistry; 1987 Apr; 26(8):2250-8. PubMed ID: 3113477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of plasma kallikrein-kinin system inhibitors from salivary glands of the blood-sucking insect Triatoma infestans.
    Isawa H; Orito Y; Jingushi N; Iwanaga S; Morita A; Chinzei Y; Yuda M
    FEBS J; 2007 Aug; 274(16):4271-86. PubMed ID: 17645545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The surface-dependent autoactivation mechanism of factor XII.
    Røjkjaer R; Schousboe I
    Eur J Biochem; 1997 Jan; 243(1-2):160-6. PubMed ID: 9030735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol).
    Laurel MT; Ratnoff OD; Everson B
    J Lab Clin Med; 1992 May; 119(5):580-5. PubMed ID: 1374787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage.
    Citarella F; Wuillemin WA; Lubbers YT; Hack CE
    Br J Haematol; 1997 Oct; 99(1):197-205. PubMed ID: 9359524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions.
    Shibayama Y; Brunnee T; Kaplan AP; Reddigari S
    Braz J Med Biol Res; 1994 Aug; 27(8):1817-28. PubMed ID: 7749371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on contact activation: effects of surface and inhibitors.
    Cameron CL; Fisslthaler B; Sherman A; Reddigari S; Silverberg M
    Med Prog Technol; 1989; 15(1-2):53-62. PubMed ID: 2530427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.